News and Publications
10/12/09
Carolus Therapeutics announces presentation at BioPartnering Europe.
Carolus Therapeutics, Inc. will present at the BioPartnering Europe conference on Monday, October 12, 2009 at 10:45 a.m. local time. The conference is being held at the QEII Conference Centre in London, United Kingdom. Court Turner, President, Chief Executive Officer and Director will provide an overview of Carolus Therapeutics, Inc., including an update on the preclinical development status of the company¹s lead program, CT-2008, and its MIF discovery program.
1/22/09
Disrupting Atherosclerosis.
SciBX
SciBX Jan 2009 (free; registration required)
1/20/09
Carolus Therapeutics Wants to be King of Cytokine Targeting.
BioWorld
BioWorld Jan 20, 2009 (subscription required)
1/22/09
Koenen RR, Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kung AJ, Hackeng TM, Mayon KH, and Weber C. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice.
Nature Medicine, 15, 97-103 (January 1, 2009)